Literature DB >> 27836804

The shape effect of magnetic mesoporous silica nanoparticles on endocytosis, biocompatibility and biodistribution.

Dan Shao1, Meng-Meng Lu2, Ya-Wei Zhao3, Fan Zhang3, Yong-Fei Tan3, Xiao Zheng3, Yue Pan3, Xuan-Ang Xiao3, Zheng Wang4, Wen-Fei Dong5, Jing Li6, Li Chen7.   

Abstract

Although the aspect ratio (AR) play a crucial role in determining biological effects of homogeneous nanomaterials, studies available concerning how the shape contributes to biological effect of heterogeneous nanomaterials is limited. To systematically clarify the shape influence on the endocytosis, biocompatibility and biodistribution of magnetic mesoporous silica nanoparticles (M-MSNPs), three FITC-labeled M-MSNPs with different aspect ratio (AR=1, 2, and 4) were specifically designed and constructed through altering the ratios of CTAB/TEOS in a modified so-gel method. We have demonstrated that long-rod M-MSNP2 possessed higher intracellular internalization amount than the short-rod M-MSNP1 and the sphere-like M-MSNP0 in both cancer cells and normal cells due to the difference in the endocytosis pathways. However, there are no significant shape effects on biocompatibility including cytotoxicity and hemolytic rate. Moreover, biodistribution in HepG2 tumor-bearing mice showed that M-MSNPs administrated intravenously were mainly presented in reticuloendothelial system (RES) organs including liver, spleen and kidney. In particular, sphere-like M-MSNP0 were easily trapped in the liver, while long-rod M-MSP2 exhibited more retention in the spleen. It is worth noting that rod-like M-MSNPs are preferentially accumulated in tumor sites than sphere-like M-MSNPs, indicating an improved drug delivery efficacy in cancer therapy. Our findings may provide useful data for deeply understanding the interaction between the different shapes and biological behavior of M-MSNPs, which is expected to give rise to a new generation of heterogeneous M-MSNPs with significantly enhanced efficacy and safety for the cancer theranostics. STATEMENT OF SIGNIFICANCE: In this work, we systematically clarified the shape influence on the endocytosis, biocompatibility and biodistribution of homogeneous nanomaterials. We have demonstrated that rod-like magnetic mesoporous silica nanoparticles (M-MSNPs) were capable of higher intracellular internalization and tumor accumulation than sphere-like M-MSNPs, which was expected to give rise to a new generation of heterogeneous M-MSNPs with significantly enhanced efficacy and safety for the cancer theranostics.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biocompatibility; Biodistribution; Endocytosis; Magnetic mesoporous silica nanoparticles; Shape; Tumor accumulation

Mesh:

Substances:

Year:  2016        PMID: 27836804     DOI: 10.1016/j.actbio.2016.11.007

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  20 in total

1.  Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties.

Authors:  Vanessa Bellat; Richard Ting; Teresa L Southard; Linda Vahdat; Henrik Molina; Joseph Fernandez; Omer Aras; Tracy Stokol; Benedict Law
Journal:  Adv Funct Mater       Date:  2018-09-14       Impact factor: 18.808

2.  Amphiphilic hyperbranched polyester coated rod mesoporous silica nanoparticles for pH-responsive doxorubicin delivery.

Authors:  Reza Bafkary; Shirin Ahmadi; Faeze Fayazi; Mehdi Karimi; Yousef Fatahi; Seyed Mostafa Ebrahimi; Fatemeh Atyabi; Rassoul Dinarvand
Journal:  Daru       Date:  2020-01-31       Impact factor: 3.117

3.  Development of Halofluorochromic Polymer Nanoassemblies for the Potential Detection of Liver Metastatic Colorectal Cancer Tumors Using Experimental and Computational Approaches.

Authors:  Derek Reichel; Louis T Curtis; Elizabeth Ehlman; B Mark Evers; Piotr Rychahou; Hermann B Frieboes; Younsoo Bae
Journal:  Pharm Res       Date:  2017-08-24       Impact factor: 4.200

Review 4.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 5.  Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.

Authors:  Rafael R Castillo; Daniel Lozano; Blanca González; Miguel Manzano; Isabel Izquierdo-Barba; María Vallet-Regí
Journal:  Expert Opin Drug Deliv       Date:  2019-04-22       Impact factor: 6.648

6.  Targeted and pH-facilitated theranostic of orthotopic gastric cancer via phase-transformation doxorubicin-encapsulated nanoparticles enhanced by low-intensity focused ultrasound (LIFU) with reduced side effect.

Authors:  Zhangluxi Liu; Haitao Ran; Zhigang Wang; Shiji Zhou; Yaxu Wang
Journal:  Int J Nanomedicine       Date:  2019-09-18

Review 7.  Nanoarchitectured prototypes of mesoporous silica nanoparticles for innovative biomedical applications.

Authors:  Ranjith Kumar Kankala; Ya-Hui Han; Hong-Ying Xia; Shi-Bin Wang; Ai-Zheng Chen
Journal:  J Nanobiotechnology       Date:  2022-03-12       Impact factor: 10.435

Review 8.  Exploiting recent trends for the synthesis and surface functionalization of mesoporous silica nanoparticles towards biomedical applications.

Authors:  Bazla Siddiqui; Asim Ur Rehman; Ihsan-Ul Haq; Amal A Al-Dossary; Abdelhamid Elaissari; Naveed Ahmed
Journal:  Int J Pharm X       Date:  2022-04-19

9.  Antibacterial and biodegradable tissue nano-adhesives for rapid wound closure.

Authors:  Meng-Meng Lu; Jing Bai; Dan Shao; Jing Qiu; Ming Li; Xiao Zheng; Yun Xiao; Zheng Wang; Zhi-Min Chang; Li Chen; Wen-Fei Dong; Chun-Bo Tang
Journal:  Int J Nanomedicine       Date:  2018-09-27

10.  Dual-responsive dithio-polydopamine coated porous CeO2 nanorods for targeted and synergistic drug delivery.

Authors:  Ying Zhang; Xiaowen Wu; Chenxi Hou; Kun Shang; Kui Yang; Zhimin Tian; Zhichao Pei; Yongquan Qu; Yuxin Pei
Journal:  Int J Nanomedicine       Date:  2018-04-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.